Sandoz Group AG (SDZ) CHF0.05
- Add to watchlist
- This stock can be held in a
Business summary
Sandoz Group AG is a Switzerland based company which is active in healthcare technology industry. The Company operates in two businesses, Generics and Biosimilars. Generics business develops, manufacture and market active ingredients and finished dosage forms of small molecule pharmaceuticals, finished dosage forms of anti-infectives and active pharmaceutical ingredients and intermediates. Biosimilars business develops, manufacture and market protein-based and other biological products which are similar to another already approved biological medicines. Company’s product portfolio comprising Generics and Biosimilars covers all therapeutic areas for patient treatment such as cardiovascular, central nervous system, oncology, anti-infectives, pain and respiratory. The Company serves customers worldwide.
Contact details
Important dates
General stock information
- Short code:
- SDZ
- ISIN:
- CH1243598427
- Market cap:
- 17.47 billion CHF
- Shares in issue:
- 438.93 million
- Sector:
- Pharmaceuticals
- Exchange:
- SIX Swiss Exchange
- Country:
- Switzerland
- Currency:
- Swiss Franc
- Indices:
- Swiss All Share Index
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.